State pension funds are looking at a $1 trillion shortfall in what they owe workers in benefits, according to new data from The Pew Charitable Trusts.
El-Erian made his comments ahead of Fed Chair Janet Yellen's speech, scheduled for Friday morning in Jackson Hole, Wyoming.
Mylan has raised the price of EpiPens more than 400 percent in recent years. The medicine inside costs $1.
Pharmaceutical company Mylan has reduced the cost of EpiPens for some people — but at the end of the day, its CEO told CNBC she has a business to run.
Under pressure, Mylan plans to boost access to its EpiPen Auto-Injector by expanding existing programs for patients who are facing higher costs.
A Donald Trump surrogate blasts a new Hillary Clinton campaign ad that tied Trump's campaign to racist hate groups.
Hillary Clinton has opened up a 10-point national lead over Donald Trump, a new poll suggests.
CNBC's Rick Santelli and Robert Laszewski discuss what's wrong with Obamacare.
There needs to be more transparency in drug pricing, and Mylan still has a lot of questions to answer, Sen. Charles Grassley said Thursday.
The FDA and Congress enabled Mylan to secure a monopoly on EpiPens and then jack up the prices, says this intellectual-property expert. So why can't they just end it?
CNBC's Meg Tirrell reports the latest on the drug price debate, Teva on a generic EpiPen and the FDA. David Maris, Wells Fargo analyst, and the "FMHR" traders weigh in.
Days after losing all his major sponsors, Ryan Lochte signed an endorsement deal with this company.
The savings came under a program where health providers coordinate care for 7.7 million Medicare beneficiaries.
As political pressure appears to mount on biotech stocks, some technical analysts say the foundation for a bounce may be building.
A jury has found that a General Motors ignition switch was not to blame for a 2011 accident.
Did you predict that oil would bounce in 2016? Nice! Did you attempt to cash in by buying the biggest oil ETF? Uh-oh.
Obamacare rates are 7 percent less in states with greater Medicaid eligibility, a new analysis says.
With low volatility and low volume, how can investors make money in today’s market? Gina Sanchez of Chantico Global and Phillip Streible of RJO Futures discuss with Brian Sullivan.
First rule about being bought by an advertising company: You’re probably going to end up selling advertising. Recode reports.